Aerie Pharmaceuticals
AERI
#5969
Rank
โ‚ฌ0.69 B
Marketcap
14,13ย โ‚ฌ
Share price
0.00%
Change (1 day)
82.29%
Change (1 year)

Revenue for Aerie Pharmaceuticals (AERI)

Revenue in 2022 (TTM): โ‚ฌ0.19 Billion

According to Aerie Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.19 Billion. In 2021 the company made a revenue of โ‚ฌ0.17 Billion an increase over the revenue in the year 2020 that were of โ‚ฌ67.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aerie Pharmaceuticals from 2013 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚ฌ0.19 B14.7%
2021 โ‚ฌ0.17 B153.61%
2020 โ‚ฌ67.59 M8.34%
2019 โ‚ฌ62.38 M195.15%
2018 โ‚ฌ21.13 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.31 B 60.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.37 M-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ57.87 B 29,103.85%๐Ÿ‡บ๐Ÿ‡ธ USA